Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives
Amusa S. Adebayo, Kafilat Agbaje, Simeon K. Adesina, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2620-2620
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The effective combination therapies with irinotecan for colorectal cancer
Yun Chai, Jingli Liu, Shuo Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Current understandings of colibactin regulation
Emily Addington, Sofia Sandalli, Andrew J. Roe
Microbiology (2024) Vol. 170, Iss. 2
Open Access | Times Cited: 5
A systematic review and network meta-analysis of RCTs: The effect of systemic immunotherapies on treatment outcomes and quality of life in patients with metastatic colorectal cancer
Yiying I. Zhu, Xiangwei Fu, Yonggang Dai
Advances in Clinical and Experimental Medicine (2025) Vol. 34, Iss. 11
Open Access
Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture
Joanna Słoka, Barbara Strzałka‐Mrozik, Sebastian Kubica, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 219-219
Open Access
Tanshinone IIA@β-cyclodextrin encapsulated with Eucommia ulmoides rubber/acetylated starch film as novel oral delivery system for therapy of orthotopic colon cancer
Rui Zhao, Haoyu Wang, Shuyao Li, et al.
Carbohydrate Polymers (2025) Vol. 353, pp. 123295-123295
Closed Access
Combined delivery of IL12 and an IL18 mutant without IL18BP-binding activity by an adenoviral vector enhances tumor specific immunity
Yan Cheng, Renjie Luo, Erguang Li
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Flavonoids and Flavonoid-Based Nanopharmaceuticals as Promising Therapeutic Strategies for Colorectal Cancer—An Updated Literature Review
Andreea Smeu, Iasmina Marcovici, Cristina Dehelean, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 231-231
Open Access
Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation
Jun Wang, Li‐Juan Zhu, Yuanyuan Li, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Establishment and biological characterization of radioresistant colorectal cancer cell lines
Tianyin Qu, Qing Dai, Jing Leng, et al.
FEBS Open Bio (2025)
Open Access
Anti-Colorectal Cancer Activity of Panax and Its Active Components, Ginsenosides: A Review
Hyun-Su Kang, Hyun Lim, Won Young Jang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2593-2593
Open Access
Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance
Leila Dadgar-Zankbar, Zahra Elahi, Aref Shariati, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p
Jia Liu, Xianbo Zhang, Meijian Yang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 2
Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy
Fei Xing, Ning Liu, Can Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis
Fangyu Hu, Lingling Zhao, Junyu Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119855-119855
Closed Access | Times Cited: 2
An updated landscape on nanopharmaceutical delivery for mitigation of colon cancer
Maria Shahzad, Huma Hameed, Ayesha Amjad, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Targeting colon cancer and normal cells with cold plasma-activated water: Exploring cytotoxic effects and cellular responses
Muttiah Barathan, N. Mohd Nasir, Vanitha Mariappan, et al.
Physics of Plasmas (2024) Vol. 31, Iss. 8
Closed Access | Times Cited: 2
Indole-3-Carboxylic Acid Enhanced Anti-cancer Potency of Doxorubicin via Induction of Cellular Senescence in Colorectal Cells
Yao Zhou, Tang Yi, Qingping Luo, et al.
Acta Poloniae Pharmaceutica - Drug Research (2024) Vol. 81, Iss. 1, pp. 109-121
Open Access | Times Cited: 1
Identification of a basement membrane-related gene signature for predicting prognosis, immune infiltration, and drug sensitivity in colorectal cancer
Xiang Shengxiao, Xinxin Sun, Yunxiang Zhu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system
Ruiqi Zhao, Mengyao Han, Sen Lin, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 10, pp. 1295-1307
Closed Access | Times Cited: 1
Obesity-Associated Colorectal Cancer
Lucía G. Gutiérrez, Omar Motiño, Daniel Barriuso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8836-8836
Open Access | Times Cited: 1
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 1
Unraveling the Spectrum of Ocular Toxicity with Oxaliplatin: Clinical Feature Analysis of Cases and Pharmacovigilance Assessment of the US Food and Drug Administration Adverse Event Reporting System Database
Wensheng Liu, Xuan Ye, Shan Han, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 12, pp. 1049-1058
Open Access | Times Cited: 1
Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance
Simona Gabriela Duta-Ion, Ioana Ruxandra Juganaru, Iulian Andrei Hotinceanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12507-12507
Open Access | Times Cited: 1
Preliminary In Vitro Assessment of Whey Protein Isolate Hydrogel with Cannabidiol as a Potential Hydrophobic Oral Drug Delivery System for Colorectal Cancer Therapy
Daniel K. Baines, Karen L. Wright, Timothy Douglas
Polymers (2024) Vol. 16, Iss. 23, pp. 3273-3273
Open Access | Times Cited: 1
Efficacy and safety of PD-1 and PD-L1 inhibitors in advanced colorectal cancer: a meta-analysis of randomized controlled trials
Zhen-Zi Wang, Yuan Liu, Kedi Wang, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top